These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15539139)

  • 1. Intrabodies: production and promise.
    Stocks MR
    Drug Discov Today; 2004 Nov; 9(22):960-6. PubMed ID: 15539139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrabodies as drug discovery tools and therapeutics.
    Stocks M
    Curr Opin Chem Biol; 2005 Aug; 9(4):359-65. PubMed ID: 15979379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular antibodies: a revolution waiting to happen?
    Stocks M
    Curr Opin Mol Ther; 2006 Feb; 8(1):17-23. PubMed ID: 16506521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular antibodies and challenges facing their use as therapeutic agents.
    Lobato MN; Rabbitts TH
    Trends Mol Med; 2003 Sep; 9(9):390-6. PubMed ID: 13129705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection and use of intracellular antibodies (intrabodies).
    Moutel S; Nizak C; Perez F
    Methods Mol Biol; 2012; 907():667-79. PubMed ID: 22907379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential of intracellular antibodies for therapeutic targeting of protein-misfolding diseases.
    Cardinale A; Biocca S
    Trends Mol Med; 2008 Sep; 14(9):373-80. PubMed ID: 18693139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Making cell-permeable antibodies (Transbody) through fusion of protein transduction domains (PTD) with single chain variable fragment (scFv) antibodies: potential advantages over antibodies expressed within the intracellular environment (Intrabody).
    Heng BC; Cao T
    Med Hypotheses; 2005; 64(6):1105-8. PubMed ID: 15823695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody engineering and modification technologies.
    Filpula D
    Biomol Eng; 2007 Jun; 24(2):201-15. PubMed ID: 17466589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrabodies: turning the humoral immune system outside in for intracellular immunization.
    Marasco WA
    Gene Ther; 1997 Jan; 4(1):11-5. PubMed ID: 9068790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific in vivo knockdown of protein function by intrabodies.
    Marschall AL; Dübel S; Böldicke T
    MAbs; 2015; 7(6):1010-35. PubMed ID: 26252565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrabodies against the EVH1 domain of Wiskott-Aldrich syndrome protein inhibit T cell receptor signaling in transgenic mice T cells.
    Sato M; Iwaya R; Ogihara K; Sawahata R; Kitani H; Chiba J; Kurosawa Y; Sekikawa K
    FEBS J; 2005 Dec; 272(23):6131-44. PubMed ID: 16302976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular antibodies (intrabodies) and their therapeutic potential.
    Lo AS; Zhu Q; Marasco WA
    Handb Exp Pharmacol; 2008; (181):343-73. PubMed ID: 18071953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbohydrates as scaffolds in drug discovery.
    Meutermans W; Le GT; Becker B
    ChemMedChem; 2006 Nov; 1(11):1164-94. PubMed ID: 16983718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrabodies as therapeutic agents.
    Kontermann RE
    Methods; 2004 Oct; 34(2):163-70. PubMed ID: 15312669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrabodies: Turning the immune system inside out for new discovery tools and therapeutics.
    Stocks MR
    Discov Med; 2005 Dec; 5(30):538-43. PubMed ID: 20704837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post genomics - from antibody production to small molecule discovery.
    Romano A; McAlpine J; Ecker D
    Curr Opin Drug Discov Devel; 2008 Mar; 11(2):166-7. PubMed ID: 18283603
    [No Abstract]   [Full Text] [Related]  

  • 17. Intracellular antibodies and cancer: new technologies offer therapeutic opportunities.
    Pérez-Martínez D; Tanaka T; Rabbitts TH
    Bioessays; 2010 Jul; 32(7):589-98. PubMed ID: 20544739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ribosome display: next-generation display technologies for production of antibodies in vitro.
    He M; Khan F
    Expert Rev Proteomics; 2005 Jun; 2(3):421-30. PubMed ID: 16000087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular antibodies (intrabodies) versus RNA interference for therapeutic applications.
    Cao T; Heng BC
    Ann Clin Lab Sci; 2005; 35(3):227-9. PubMed ID: 16081577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.